Form and function of developing heart valves: Coordination by extracellular matrix and growth factor signaling

Journal of Molecular Medicine

Volumn 81, Issue 7, 2003, Pages 392-403

  Schroeder, Joyce A ^a   Jackson, Leslie F ^b   Lee, David C ^b   Camenisch, Todd D ^c  

^a University of Arizona   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Endocardial cushion morphogenesis; erbB; Extracellular matrix; Heart valve; Hyaluronan

Indexed keywords

AMPHIREGULIN; BETACELLULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; GROWTH PROMOTOR; HYALURONIC ACID; INTEGRIN; LIGAND; NEU DIFFERENTIATION FACTOR; POLYPEPTIDE; PROTEIN TYROSINE KINASE; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOLOGY; ENDOCARDIUM; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART DEVELOPMENT; HEART VALVE; HUMAN; METABOLISM; MITRAL VALVE; MORPHOGENESIS; MOUSE; NONHUMAN; PHYSIOLOGY; PULMONARY VALVE; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOCARDIUM; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH SUBSTANCES; HEART; HEART VALVES; HUMANS; HYALURONIC ACID; MORPHOGENESIS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 0042368795     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-003-0456-5     Document Type: Review

References (125)

1. Allan LD, Crawford DC, Chita SK, Anderson RH, Tynan MJ (1986) Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol 58:334-337
2. Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890-1900
3. Srivastava D (2001) Genetic assembly of the heart: implications for congenital heart disease. Annu Rev Physiol 63:451-469
4. Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, Gharib M (2003) Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 421:172-177
5. Epstein JA, Buck CA (2000) Transcriptional regulation of cardiac development: implications for congenital heart disease and DiGeorge syndrome. Pediatr Res 48:717-724
6. Srivastava D, Olson EN (2000) A genetic blueprint for cardiac development. Nature 407:221-226
7. Chien KR, Olson EN (2002) Converging pathways and principles in heart development and disease: CV@CSH. Cell 110:153-162
8. Cripps RM, Olson EN (2002) Control of cardiac development by an evolutionarily conserved transcriptional network. Dev Biol 246:14-28
9. Anderson RH, Webb S, Brown NA (1998) The mouse with trisomy 16 as a model of human hearts with common atrioventricular junction. Cardiovasc Res 39:155-164
10. Webb S, Brown NA, Anderson RH (1998) Formation of the atrioventricular septal structures in the normal mouse. Circ Res 82:645-656
11. Pexieder T (1995) Conotruncus and its septation at the advent of the molecular biology era. In: Clark EB, Markwald RR, Takao A (eds) Developmental mechanisms of heart disease. Futura, Armonk, pp 227-247
12. Hoff MJ van den, Moorman AF, Ruijter JM, et al (1999) Myocardialization of the cardiac outflow tract. Dev Biol 212:477-490
13. Wenink AC, Gittenberger-de Groot AC (1986) Embryology of the mitral valve. Int J Cardiol 11:75-84
14. Runyan RB, Markwald RR (1983) Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. Dev Biol 95:108-114
15. Boyer AS, Ayerinskas, II, Vincent EB, McKinney LA, Weeks DL, Runyan RB (1999) TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 208:530-545
16. Yamagishi T, Nakajima Y, Miyazono K, Nakamura H (1999) Bone morphogenetic protein-2 acts synergistically with transforming growth factor-beta3 during endothelial-mesenchymal transformation in the developing chick heart. J Cell Physiol 180:35-45
17. Brown CB, Boyer AS, Runyan RB, Barnett JV (1996) Antibodies to the Type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev Biol 174:248-257
18. Brown CB, Boyer AS, Runyan RB, Barnett JV (1999) Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 283:2080-2082
19. Kaartinen V, Voncken JW, Shuler C, et al (1995) Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421
20. Camenisch TD, Molin DG, Person A, et al (2002) Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248:170-181
21. Markwald RR, Fitzharris TP, Bank H, Bernanke DH (1978) Structural analyses on the matrical organization of glycosaminoglycans in developing endocardial cushions. Dev Biol 62:292-316
22. Nakamura A, Manasek FJ (1981) An experimental study of the relation of cardiac jelly to the shape of the early chick embryonic heart. J Embryol Exp Morphol 65:235-256
23. Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27-33
24. Hascall VC (2000) Hyaluronan, a common thread. Glycoconj J 17:607-616
25. Toole BP (1997) Hyaluronan in morphogenesis. J Intern Med 242:35-40
26. Camenisch TD, Spicer AP, Brehm-Gibson T, et al (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106:349-360
27. Baldwin HS, Lloyd TR, Solursh M (1994) Hyaluronate degradation affects ventricular function of the early postlooped embryonic rat heart in situ. Circ Res 74:244-252
28. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202:56-66
29. Camenisch TD, Biesterfeldt J, Brehm-Gibson T, Bradley J, McDonald JA (2001) Regulation of cardiac cushion development by hyaluronan. Exp Clin Cardiol 6:4-10
30. Walsh EC, Stainier DY (2001) Udp-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 293:1670-1673
31. Klewer SE, Krob SL, Kolker SJ, Kitten GT (1998) Expression of type VI collagen in the developing mouse heart. Dev Dyn 211:248-255
32. Rongish BJ, Drake CJ, Argraves WS, Little CD (1998) Identification of the developmental marker, JB3-antigen, as fibrillin-2 and its de novo organization into embryonic microfibrous arrays. Dev Dyn 212:461-471
33. Miosge N, Sasaki T, Chu ML, Herken R, Timpl R (1998) Ultrastructural localization of microfibrillar fibulin-1 and fibulin-2 during heart development indicates a switch in molecular associations. Cell Mol Life Sci 54:606-613
34. Tsuda T, Wang H, Timpl R, Chu ML (2001) Fibulin-2 expression marks transformed mesenchymal cells in developing cardiac valves, aortic arch vessels, and coronary vessels. Dev Dyn 222:89-100
35. Eisenberg LM, Markwald RR (1995) Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77:1-6
36. LeBaron RG, Zimmermann DR, Ruoslahti E (1992) Hyaluronate binding properties of versican. J Biol Chem 267:10003-10010
37. Aspberg A, Adam S, Kostka G, Timpl R, Heinegard D (1999) Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem 274:20444-20449
38. Binari RC, Staveley BE, Johnson WA, Godavarti R, Sasisekharan R, Manoukian AS (1997) Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling. Development 124:2623-2632
39. Fujise M, Takeo S, Kamimura K, et al (2003) Dally regulates Dpp morphogen gradient formation in the Drosophila wing. Development 130:1515-1522
40. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
41. Howe A, Aplin AE, Alahari SK, Juliano RL (1998) Integrin signaling and cell growth control. Curr Opin Cell Biol 10:220-231
42. Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KL 3rd (1994) Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 91:8132-8136
43. Schroeder JA, Lee DC (1997) Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia 2:119-129
44. Falls DL (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14-30
45. Riese DJ 2nd, Komurasaki T, Plowman GD, Stern DF (1998) Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J Biol Chem 273:11288-11294
46. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M (1997) Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16:1268-1278
47. Pinkas-Kramarski R, Soussan L, Waterman H, et al (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15:2452-2467
48. Garrett TP, McKern NM, Lou M, et al (2003) The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell 11:495-505
49. Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA (2003) EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11:507-517
50. Alroy I, Yarden Y (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410:83-86
51. Carpenter G (2000) The EGF receptor: a nexus for trafficking and signaling. Bioessays 22:697-707
52. Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE (1998) ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol Cell Biol 18:5042-5051
53. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE (1999) ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem 274:17209-17218
54. Amundadottir LT, Leder P (1998) Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16:737-746
55. Daly JM, Olayioye MA, Wong AM, et al (1999) NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways. Oncogene 18:3440-3451
56. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ (1998) Increasing complexity of Ras signaling. Oncogene 17:1395-1413
57. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19:3159-3167
58. Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R (2001) Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Cytometry 44:338-348
59. Brutsaert DL (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83:59-115
60. Hertig CM, Kubalak SW, Wang Y, Chien KR (1999) Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis. J Biol Chem 274:37362-37369
61. Meyer D, Birchmeier C (1995) Multiple essential functions of neuregulin in development. Nature 378:386-390 (erratum 378:753)
62. Erickson SL, O'Shea KS, Ghaboosi N, et al (1997) ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124:4999-5011
63. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA (2002) Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 8:850-855
64. Gassmann M, Casagranda F, Orioli D, et al (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378:390-394
65. Chan R, Hardy WR, Laing MA, Hardy SE, Muller WJ (2002) The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development. Mol Cell Biol 22:1073-1078
66. Nebigil CG, Maroteaux L (2001) A novel role for serotonin in heart. Trends Cardiovasc Med 11:329-335
67. Chen B, Bronson RT, Klaman LD, et al (2000) Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 24:296-299
68. Iwamoto R, Yamazaki S, Asakura M, et al (2003) Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA 100:3221-3226
69. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC (1997) Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 272:27913-27918
70. Lakkis MM, Epstein JA (1998) Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125:4359-4367
71. Lee H, Akita RW, Sliwkowski MX, Maihle NJ (2001) A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. Cancer Res 61:4467-4473
72. Peschon JJ, Slack JL, Reddy P, et al (1998) An essential role for ectodomain shedding in mammalian development. Science 282:1281-1284
73. Sunnarborg SW, Hinkle CL, Stevenson M, et al (2002) Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277:12838-12845
74. Gaussin V, Van de Putte T, Mishina Y, et al (2002) Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci USA 99:2878-2883
75. Hierck BP, Poelmann RE, van Iperen L, Brouwer A, Gittenberger-de Groot AC (1996) Differential expression of alpha-6 and other subunits of laminin binding integrins during development of the murine heart. Dev Dyn 206:100-111
76. Gottlieb PD, Pierce SA, Sims RJ, et al (2002) Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 31:25-32
77. Jones CM, Lyons KM, Hogan BL (1991) Involvement of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 111:531-542
78. Winnier G, Blessing M, Labosky PA, Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116
79. Kim RY, Robertson EJ, Solloway MJ (2001) Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 235:449-466
80. Zhu X, Lough J (1996) Expression of alternatively spliced and canonical basic fibroblast growth factor mRNAs in the early embryo and developing heart. Dev Dyn 206:139-145
81. Runyan RB, Potts JD, Sharma RV, Loeber CP, Chiang JJ, Bhalla RC (1990) Signal transduction of a tissue interaction during embryonic heart development. Cell Regulation 1:301-313
82. Pompa JL de la, Timmerman LA, Takimoto H, et al (1998) Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182-186
83. Kumai M, Nishii K, Nakamura K, Takeda N, Suzuki M, Shibata Y (2000) Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 127:3501-3512
84. Gaio U, Schweickert A, Fischer A, et al (1999) A role of the cryptic gene in the correct establishment of the left-right axis. Curr Biol 9:1339-1342
85. Crossin KL, Hoffman S (1991) Expression of adhesion molecules during the formation and differentiation of the avian endocardial cushion tissue. Dev Biol 145:277-286
86. Yanagisawa H, Hammer RE, Richardson JA, et al (2000) Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 105:1373-1382
87. Frank DU, Fotheringham LK, Brewer JA, et al (2002) An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129:4591-4603
88. Obata K, Koide M, Nagata K, et al (2001) Role of FK506-binding protein 12 in development of the chick embryonic heart. Biochem Biophys Res Commun 283:613-620
89. Yazawa S, Obata K, Iio A, et al (2003) Heart-selective expression of the chicken FK506-binding protein (FKBP) 12.6 gene during embryonic development. Dev Dyn 226:33-41
90. Svensson EC, Huggins GS, Lin H, et al (2000) A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat Genet 25:353-356
91. Crispino JD, Lodish MB, Thurberg BL, et al (2001) Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 15:839-844
92. Nemer G, Nemer M (2002) Cooperative interaction between GATA5 and NF-ATc regulates endothelial-endocardial differentiation of cardiogenic cells. Development 129:4045-4055
93. Thery C, Stern CD (1996) Roles of kringle domain-containing serine proteases in epithelial-mesenchymal transitions during embryonic development. Acta Anat (Basel) 156:162-172
94. Evans SM, O'Brien TX (1993) Expression of the helix-loop-helix factor Id during mouse embryonic development. Dev Biol 159:485-499
95. Nakajima Y, Miyazono K, Kato M, Takase M, Yamagishi T, Nakamura H (1997) Extracellular fibrillar structure of latent TGF beta binding protein-1: role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J Cell Biol 136:193-204
96. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ (2001) Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 103:183-188
97. Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R (2002) Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 91:158-164
98. Liu C, Liu W, Palie J, Lu MF, Brown NA, Martin JF (2002) Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions. Development 129:5081-5091
99. Lin CR, Kioussi C, O'Connell S, et al (1999) Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 401:279-282
100. Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E, Madri JA (2003) Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 160:605-615
101. Candia AF, Hu J, Crosby J, et al (1992) Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos. Development 116:1123-1136
102. Kwang SJ, Bragger SM, Lazik A, et al (2002) Msx2 is an immediate downstream effector of Pax3 in the development of the murine cardiac neural crest. Development 129:527-538
103. Ranger AM, Grusby MJ, Hodge MR, et al (1998) The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186-190
104. Lee TC, Zhao YD, Courtman DW, Stewart DJ (2000) Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101:2345-2348
105. Biben C, Harvey RP (1997) Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHand during murine heart development. Genes Dev 11:1357-1369
106. Robbins JR, McGuire PG, Wehrle-Haller B, Rogers SL (1999) Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. Dev Biol 212:255-263
107. Zhao Z, Rivkees SA (2003) Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev Dyn 226:24-32
108. Bouman HG, Broekhuizen ML, Baasten AM, Gittenberger-de Groot AC, Wenink AC (1998) Diminished growth of atrioventricular cushion tissue in stage 24 retinoic acid-treated chicken embryos. Dev Dyn 213:50-58
109. Bouman HG, Broekhuizen LA, Baasten AM, Gittenberger-de Groot AC, Wenink AC (1997) Stereological study of stage 34 chicken hearts with looping disturbances after retinoic acid treatment: disturbed growth of myocardium and atrioventricular cushion tissue. Anat Rec 248:242-250
110. Gruber PJ, Kubalak SW, Pexieder T, Sucov HM, Evans RM, Chien KR (1996) RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J Clin Invest 98:1332-1343
111. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM (1994) RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8:1007-1018
112. Sucov HM, Evans RM (1995) Retinoic acid and retinoic acid receptors in development. Mol Neurobiol 10:169-184
113. Kastner P, Messaddeq N, Mark M, et al (1997) Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes. Development 124:4749-4758
114. Kruithof BP, Van Den Hoff MJ, Wessels A, Moorman AF (2003) Cardiac muscle cell formation after development of the linear heart tube. Dev Dyn 227:1-13
115. Romano LA, Runyan RB (2000) Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. Dev Biol 223:91-102
116. Romano LA, Runyan RB (1999) Slug is a mediator of epithelial-mesenchymal cell transformation in the developing chicken heart. Dev Biol 212:243-254
117. Galvin KM, Donovan MJ, Lynch CA, et al (2000) A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24:171-174
118. Ya J, Schilham MW, Deboer PAJ, Moorman AFM, Clevers H, Lamers WH (1998) Sox4-deficiency syndrome in mice Is an animal model For common trunk. Circ Res 83:986-994
119. Nakajima Y, Mironov V, Yamagishi T, Nakamura H, Markwald RR (1997) Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn 209:296-309
120. Puri MC, Partanen J, Rossant J, Bernstein A (1999) Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126:4569-4580
121. McGuire PG, Alexander SM (1993) Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro. Development 118:931-939
122. Gorny KN, Brauer PR (1999) Urokinase regulates embryonic cardiac cushion cell migration without converting plasminogen. Anat Rec 256:269-278
123. Dor Y, Camenisch TD, Itin A, et al (2001) A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart disease. Development 128:1531-1538
124. Dor Y, Klewer SE, McDonald JA, Keshet E, Camenisch TD (2003) VEGF modulates early heart valve formation. Anat Rec 271 A:202-208
125. Meier T, Masciulli F, Moore C, et al (1998) Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins. J Cell Biol 141:715-726